Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 21, 2026 at 12:37 PM UTC
| NCT Number | NCT05307705 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 260 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Eli Lilly and Company |
| Last Updated on CT.gov | July 20, 2026 (Yesterday) |
As of July 21, 2026: Clinical trial NCT05307705 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 17 locations across the United States. The study is sponsored by Eli Lilly and Company. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05307705 is actively recruiting participants as of July 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05307705 was last updated Yesterday (July 20, 2026). HelloStudys verifies this status automatically.